Discussion
Immune thrombocytopenia (ITP) can occur in people with antiphospholipid syndrome (APS), another immune disorder — and people who have co-occurring ITP and APS almost…
HMB-002, an experimental antibody-based treatment from Hemab Therapeutics for von Willebrand disease (VWD), increased levels of von Willebrand factor (VWF) and improved measures of blood clotting in a clinical trial. That’s according to initial data from the Phase 1/2 Velora Pioneer study (NCT06754852), which showed that a…
Latest news & perspectives
Discussion
Discussion
At the ripe young age of 8, I should have been worrying about times tables, which Enid Blyton book I’d read next, and whether my…
